FDA Orange Book · active-ingredient family
Aspirin; meprobamate
Aspirin; meprobamate is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:EQUAGESIC · NDA 011702
1
Brand (NDA)
4
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| EQUAGESIC | SUN PHARM INDUSTRIES | NDA 011702 | — | Dec 29, 1983 |
Generic (ANDA) products (4)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MEPRO-ASPIRIN | SANDOZ | ANDA 089127 | — | Mar 02, 1987 | |
| MEPROBAMATE AND ASPIRIN | PAR PHARM | ANDA 089126 | — | Aug 19, 1986 | |
| Q-GESIC | QUANTUM PHARMICS | ANDA 088740 | — | Jun 01, 1984 | |
| MICRAININ | MEDPOINTE PHARM HLC | ANDA 084978 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Aspirin; meprobamate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

